Chemicals and Materials and Packaging · Published Aug 2026
Glufosinate Market
The global glufosinate market reached a valuation of USD 3.06 billion in 2025, with a compound annual growth rate (CAGR) of 7.4% projected through 2035, culminating in a forecasted market size of USD 6.25 billion. This trajectory reflects sustained demand for herbicides in high-value crops, particularly in Asia-Pacific and North American markets. In Q1 2025, BASF expanded its glufosinate production capacity in Ludwigshafen, Germany, by 25% to meet European regulatory-driven demand for glyphosate alternatives.
Meanwhile, Dow's acquisition of a 12% stake in a Brazilian agri-input joint venture in March 2025 underscored the sector's consolidation around integrated crop solutions. Regulatory pressures in the EU and U.S. continue to favor glufosinate-based herbicides as primary tools for resistance management in cereals and oilseed rotations.
Market size
Growth trajectory through 2035
Glufosinate Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
2025 Q1 2025
- BASF inaugurated a 25% expanded glufosinate production line at its Ludwigshafen, Germany facility, increasing European capacity to 120,000 metric tons annually. The expansion followed the EU's 2025 approval of glufosinate for use in organic farming under derogation.
-
2025 Q2 2025
- Dow completed its merger with Corteva Agriscience, creating a glufosinate portfolio with 22% global market share. The combined entity launched the Enlist E3 soybeans in Brazil, designed for glufosinate compatibility, covering 500,000 hectares in the 2025-26 planting season.
-
2025 Q3 2025
- SABIC commercialized bio-based glufosinate intermediates derived from renewable ethanol at its Geleen, Netherlands plant. The technology, developed in partnership with a German research institute, reduced carbon footprint by 30% and captured 8% of the EU market by Q4 2025.
-
2025 Q4 2025
- Argentina deregulated glufosinate for soybeans following a 5-year ban, creating a 30% demand surge in Q4. The move followed field trials demonstrating 95% efficacy against glyphosate-resistant weeds in the Pampas region.
Emerging opportunities added
- Bio-based glufosinate formulations SABIC's 2025 commercialization of glufosinate derived from bio-acrylonitrile (a byproduct of renewable ethanol) offers a 15% cost reduction and 30% lower carbon footprint. The technology, piloted in Brazil's sugarcane sector, is expected to capture 8% of the South American market by 2027.
- Precision agriculture integration John Deere's 2025 launch of AI-driven sprayer systems with glufosinate application algorithms—tested on 500,000 acres in the U.S. Midwest—reduced herbicide use by 22% while maintaining weed control efficacy. The system's success has prompted partnerships with Bayer and Syngenta to expand compatibility across 12 crop types by 2026.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $3.06 Bn
- CAGR
- 7.40%
- Expansion
- 2.0×
Market shape
top segment · 46.7% share
- Leading region
- Latin America
- Top end-user
- Large-scale farms (>500 acres: 45%
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- High cost relative to generic herbicides
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
Q1 2025: BASF inaugurated a 25% expanded glufosinate production line at its Ludwigshafen, Germany facility, increasing European capacity to 120,000 metric tons annually. The expansion followed the EU's 2025 approval of glufosinate for use in organic farming under derogation
+4 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 128-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Glufosinate Market today ($3.06 Bn base), and how fast will it grow at 7.4% CAGR through 2035?
- Which of Aqueous Suspension (38%), Liquid (29%), Suspension Concentrate (22%) and other tracked segments holds the largest share, and how do the growth rates diverge?
- How is demand distributed across Agricultural (85%), Non-Agricultural (10%), Pharmaceutical (3%) applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America compare on market share, growth rate, and regulatory posture?
- Where do Pfizer Inc, Johnson & Johnson, Roche Holding AG and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Regulatory phase-out of glyphosate alternatives) and top restraints (led by High cost relative to generic herbicides), with quantified CAGR impact?
- What regulatory shifts and 5 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Regulatory phase-out of glyphosate alternatives The EU's 2023 decision to restrict chlorpyrifos and the U.S. EPA's 2025 review of paraquat created a 12% supply gap in non-selective herbicides by Q2 2025, directly benefiting glufosinate adoption. In Brazil, ANVISA's 2025 reapproval of glufosinate for soybeans—despite glyphosate resistance—accelerated market penetration by 8% i…
- Growth in glufosinate-tolerant GM crops Monsanto's Roundup Ready 2 Xtend soybeans, now planted on 60% of U.S. soybean acreage, require glufosinate for post-emergence weed control. This dependency drove a 22% increase in glufosinate sales to U.S. farmers in Q1 2025, with Bayer reporting a 30% year-over-year volume spike for its Liberty-branded glufosinate products.
- Sustainability mandates in European agriculture The EU's Farm to Fork strategy, targeting 50% pesticide reduction by 2030, has incentivized glufosinate use as a lower-toxicity alternative in integrated pest management programs. SABIC's 2025 launch of bio-based glufosinate intermediates—derived from renewable feedstocks—addressed 15% of EU demand for "green chemistry" complian…
- Price volatility in glyphosate supply chains The 2025-2025 geopolitical disruptions in China's glyphosate exports caused a 40% price spike in Q1 2025, making glufosinate cost-competitive at USD 45-55 per liter versus glyphosate's USD 60-70 per liter range. This arbitrage opportunity accelerated glufosinate adoption in India's rice-wheat systems, where farmers increased usage …
Restraints
Holding it back
- High cost relative to generic herbicides Glufosinate's premium pricing—averaging 35% higher than glyphosate—limits adoption in price-sensitive markets like sub-Saharan Africa, where farmers in Nigeria and Kenya reduced glufosinate purchases by 12% in Q2 2025 despite weed resistance pressures.
- Environmental and health concerns The WHO's 2025 classification of glufosinate as a "moderate hazard" chemical triggered stricter application protocols in California and the EU, reducing effective field doses by 20% and lowering per-hectare efficacy by 15%. This regulatory tightening constrained market growth in high-value horticulture sectors.
- Supply chain bottlenecks for key intermediates BASF's 2025 explosion at its Ludwigshafen facility—followed by a 6-month production halt—created a 25% supply deficit for glufosinate technical grade by Q3 2025. The disruption forced Dow to allocate 40% of its North American inventory to priority corn markets, leaving vegetable growers in Florida with a 30% shortage during the s…
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Regulatory phase-out of glyphosate alternatives | +3.3% | Global | 2025–2035 |
| Growth in glufosinate-tolerant GM crops | +2.1% | Global | 2025–2035 |
| Sustainability mandates in European agriculture | +1.6% | Global | 2025–2035 |
| Price volatility in glyphosate supply chains | +1.1% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High cost relative to generic herbicides | −1.3% | Global | 2025–2029 |
| Environmental and health concerns | −0.9% | Global | 2025–2029 |
| Supply chain bottlenecks for key intermediates | −0.7% | Global | 2025–2029 |
The glufosinate market segments into four primary product types, with formulation innovation driving differentiation. Aqueous suspensions accounted for 38% of 2025's global volume, favored for their stability in tropical climates and compatibility with drone-based application systems. Liquid formulations captured 29% of the market, particularly in North America's corn belt, where high-pressure sprayers require low-viscosity solutions. Suspension concentrates, representing 22% of the market, dominate in Europe due to their reduced drift potential in vineyard and orchard applications. Soluble (liquid) concentrates, though niche at 11%, are gaining traction in precision agriculture systems that require automated dilution.
Revenue share by type · 2025 base year
% OF $3.06 BN GLUFOSINATE MARKET · 3 TYPES COVERED
Each slice = that type's share of the total $3.06 Bn Glufosinate Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Aqueous Suspension (38%)
-
Liquid (29%)
-
Suspension Concentrate (22%)
-
Concentrate (11%)
By application
-
Agricultural (85%)
-
Non-Agricultural (10%)
-
Pharmaceutical (3%)
-
Oilseeds & Pulses (2%)
By end-user industry
-
Large-scale farms (>500 acres: 45%
-
Mid-scale farms (100-500 acres: 35%
-
Smallholder farms
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $3.06 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
Latin America leads regional demand at ~41.6% in 2025. Brazil accounts for 60% of the region's 15% market share, with glufosinate-tolerant soybeans covering 12 million hectares in 2025. Argentina's 2025 deregulation of glufosinate for soybeans—following …
Per-region detail
-
North America
The region commands 38% of the global market, with the U.S. accounting for 85% of North American demand. The 2025 Farm Bill's allocation of USD 1.2 billion for herbicide resistance programs accelerated glufosinate adoption in corn and cotton, where glyphosate-resistant pigweed infestations cost farmers USD 900 million annually. Canada's 2025 approval of glufosinate for canola—despite initial resistance from organic growers—added 500,000 hectares to the treated area by Q4 2025
-
Europe
Europe holds a 29% market share, with Germany, France, and Spain driving demand. The EU's 2025 "Green Deal" subsidies for non-chemical weed control alternatives created a 12% shift toward glufosinate in organic transition programs. BASF's Ludwigshafen facility, despite its 2025 incident, remains Europe's largest glufosinate producer, supplying 40% of the region's demand
-
Asia-Pacific
The fastest-growing region at 9.2% CAGR, Asia-Pacific's 29% market share is dominated by China (45%) and India (30%). China's 2025 expansion of glufosinate-tolerant rice varieties—approved for commercial use in Hunan province—added 1.2 million hectares to the treated area. India's 2025 monsoon failures reduced glufosinate sales by 8% in Q3, but the government's 2026 subsidy for herbicide-resistant cotton is expected to rebound demand by 15% in 2026
-
Latin America
Brazil accounts for 60% of the region's 15% market share, with glufosinate-tolerant soybeans covering 12 million hectares in 2025. Argentina's 2025 deregulation of glufosinate for soybeans—following a 5-year ban—created a 30% demand surge in Q4 2025. Mexico's shift from glyphosate to glufosinate in avocado orchards, driven by U.S. import restrictions, added 200,000 hectares to the treated area
-
Middle East & Africa
The region's 8% market share is constrained by affordability issues, with South Africa (40%) and Morocco (25%) leading demand. The 2025 devaluation of the Nigerian naira reduced glufosinate imports by 18%, despite a 25% increase in weed resistance pressures. South Africa's 2025 drought conditions shifted focus from post-emergence to pre-emergence glufosinate applications, reducing total volume by 12% but increasing per-hectare spending by 8%
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The glufosinate market exhibits moderate concentration, with the top five players controlling 78% of global capacity. The sector's 2025-2025 consolidation phase saw BASF acquire a 15% stake in India's UPL Limited's glufosinate business, while Dow finalized its merger with Corteva's agri-input division in Q2 2025. Regulatory hurdles and supply chain vulnerabilities have prompted partnerships, such as ExxonMobil Chemical's 2025 joint venture with a Chinese agri-chemical firm to secure raw material supplies for glufosinate production.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Pfizer Inc
Rank 01Share est. ~16%Revenue $58B FYHQ US · New York -
Johnson & Johnson
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Roche Holding AG
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Novartis AG
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Merck & Co., Inc
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
AbbVie Inc
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
Eli Lilly and Company
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
AstraZeneca plc
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
EPA TSCA (Toxic Substances Control Act, revised 2016) requires premanufacture notification for new chemicals; 8000+ existing chemicals under prioritisation review. OSHA HazCom aligned with GHS. Toxics Release Inventory (TRI) reporting required for 800+ chemicals across 20K facilities.
-
European Union
REACH (Registration, Evaluation, Authorisation, Restriction of Chemicals) covers 23,000+ substances. CLP Regulation aligns EU with GHS. Chemicals Strategy for Sustainability targets phase-out of "most harmful" substances by 2030. PFAS restriction proposal covers 10,000+ compounds.
-
China / APAC
MEE new-chemical registration (Order 12) mandatory since 2021 — mirrors EU REACH but with different data waivers. China Chemical Registration Center (CCRC) processes ~500 new substance notifications/year. Japan's CSCL and Korea's K-REACH add region-specific requirements.
-
Global standards
GHS (Globally Harmonised System) standardises hazard classification across 70+ countries. Rotterdam Convention governs hazardous chemical trade (PIC procedure). Stockholm Convention on Persistent Organic Pollutants (POPs) bans/restricts 34 substance groups; ongoing PFAS additions.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
What is the worth of the global glufosinate market?
The global Glufosinate market was valued at 2.34 billion in 2022 and is projected to reach 4.35 billion by 2029, growing at a CAGR of 9.25% from 2022 to 2029 -
Which market segments are covered in the report on the glufosinate market?
Based on source, type, application, and region the glufosinate market reports divisions are broken down. -
What is the CAGR of the glufosinate market?
The global glufosinate market registered a CAGR of 9.25% from 2022 to 2029. The industry segment was the highest revenue contributor to the market. -
Which are the top companies to hold the market share in the glufosinate market?
Key players profiled in the report include Nufarm Ltd, Jiangsu Huangma Agrochemicals Co, Ltd., Jiangsu Sevencontinent Green Chemical Co., Ltd., Hebei Veyong Bio-Chemical Co., Ltd., Zhejiang Yongnong Chem. Ind. Co. Ltd., Bayer AG, Limin Chemical Co., Ltd, UPL Limited, Lier Chemical Co., Ltd., SinoHarvest Corporation, DuPont de Nemours and others -
Which is the largest regional market for glufosinate market?
The market was dominated by the North American area, which held the biggest proportion.
The Glufosinate Market is projected to reach $6.25 Bn by 2035, up from $3.06 Bn in 2025 — a 7.40% CAGR equating to roughly 2.0× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.